登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>HLA-DRA1*0101 & HLA-DRB1*1101 >HL1-H82W6

Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Peptide free, MALS verified)

表达区间及表达系统(Source)

Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (HL1-H82W6) is expressed from human 293 cells (HEK293). It contains AA Ile 26 - Glu 216 (HLA-DRA1*01:01) & Gly 30 - Lys 227 (HLA-DRB1*11:01) (Accession # CAI2388006.1 (HLA-DRA1*01:01) & CAI2388099.1 (HLA-DRB1*11:01)).

Predicted N-terminus: Ile 26 & Gly 30

Request for sequence

蛋白结构(Molecular Characterization)

Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein, produced by co-expression of HLA-DRA1*01:01 and HLA-DRB1*11:01, has a calculated MW of 29.2 kDa (HLA-DRA1*01:01) and 29.2 kDa (HLA-DRB1*11:01). Subunit HLA-DRA1*01:01 is fused with a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™) and subunit HLA-DRB1*11:01 contains no tag. The protein migrates as 40-43 kDa and 35-38 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

标记(Labeling)

Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

蛋白标记度(Protein Ratio)

Passed as determined by the HABA assay / binding ELISA.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>90% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

HLA-DRA1*0101 & HLA-DRB1*1101 SDS-PAGE

Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

SEC-MALS

HLA-DRA1*0101 & HLA-DRB1*1101 SEC-MALS

The purity of Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Cat. No. HL1-H82W6) is more than 90% and the molecular weight of this protein is around 55-75 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-ELISA

HLA-DRA1*0101 & HLA-DRB1*1101 ELISA

Immobilized Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Cat. No. HL1-H82W6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-HLA-DR Antibody, Human IgG1 with a linear range of 0.06-2 ng/mL (QC tested).

Protocol

 

前沿进展

 
 
货号/价格
产品推荐
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定